Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. MicroStrategy's Bitcoin Stash Now In The Green as Crypto Assets Soar
  2. JetBlue Sees Wider Than Expected Loss In Q4, Cuts FY23 Outlook; Stock Dips In Premarket – Update
  3. Bitcoin Miners Dump $55 Million Worth of $BTC Amid Price Drop to Key Support Level
  4. Bitcoin, ETH, XRP, ADA Get Stuck In Tight Ranges As Investors Attune To The Jackson Hole Symposium
  5. MicroStrategy’s Financial Health At Risk After Enormous $3.4 Billion Bitcoin Bet: Fortune Report